InvestorsHub Logo
Post# of 252821
Next 10
Followers 618
Posts 76741
Boards Moderated 15
Alias Born 01/30/2006

Re: drbio45 post# 50313

Saturday, 07/28/2007 11:39:16 AM

Saturday, July 28, 2007 11:39:16 AM

Post# of 252821
"Studies" and not "opinions"

Neurosurgery. 2007 Feb;60(2 Suppl 1):ONS147-56; discussion ONS156.

A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking.Ho AK, Fu D, Cotrutz C, Hancock SL, Chang SD, Gibbs IC, Maurer CR, Adler JR.
Department of Radiation Oncology, Stanford University Medical Center, Stanford, California 94305-5304, USA. tonyho22003@yahoo.com

OBJECTIVE: New technology has enabled the increasing use of radiosurgery to ablate spinal lesions. The first generation of the CyberKnife (Accuray, Inc., Sunnyvale, CA) image-guided radiosurgery system required implanted radiopaque markers (fiducials) to localize spinal targets. A recently developed and now commercially available spine tracking technology called Xsight (Accuray, Inc.) tracks skeletal structures and eliminates the need for implanted fiducials. The Xsight system localizes spinal targets by direct reference to the adjacent vertebral elements. This study sought to measure the accuracy of Xsight spine tracking and provide a qualitative assessment of overall system performance. METHODS: Total system error, which is defined as the distance between the centroids of the planned and delivered dose distributions and represents all possible treatment planning and delivery errors, was measured using a realistic, anthropomorphic head-and-neck phantom. The Xsight tracking system error component of total system error was also computed by retrospectively analyzing image data obtained from eleven patients with a total of 44 implanted fiducials who underwent CyberKnife spinal radiosurgery. RESULTS: The total system error of the Xsight targeting technology was measured to be 0.61 mm. The tracking system error component was found to be 0.49 mm. CONCLUSION: The Xsight spine tracking system is practically important because it is accurate and eliminates the use of implanted fiducials. Experience has shown this technology to be robust under a wide range of clinical circumstances.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.